Target intelligence / Profile preview

Gram-negative bacterial outer membrane phospholipids and divalent cation cross-bridges

Molecular classification
Other
01

Overview

The outer membrane of Gram-negative bacteria acts as a formidable permeability barrier, protecting the cell from environmental stressors and many antibiotics (Nikaido, 2003). This structural integrity is largely maintained by the presence of divalent cations, specifically magnesium (Mg2+) and calcium (Ca2+), which form essential cross-bridges between negatively charged phosphate groups on lipopolysaccharides (LPS) and phospholipids (Clifton et al., 2015). These ionic interactions neutralize electrostatic repulsion between anionic lipid heads, effectively 'zipping' the membrane components together to create a dense, stable leaflet (Hancock, 1997). Disruption of these cation bridges is a primary mechanism for several classes of antibiotics, most notably the polymyxins, such as colistin and polymyxin B (Trimble et al., 2016). These cationic drugs possess a higher affinity for the lipid phosphate groups than the native divalent cations, allowing them to competitively displace the ions and destabilize the membrane (Moore et al., 1986). This displacement leads to increased membrane permeability, a phenomenon termed 'self-promoted uptake,' which facilitates the drug's entry and eventual disruption of the cytoplasmic membrane (Hancock, 1984). Targeting these cross-bridges is a critical strategy for treating multidrug-resistant infections caused by pathogens such as Pseudomonas aeruginosa and Acinetobacter baumannii (Trimble et al., 2016). However, therapeutic use is often limited by the potential for nephrotoxicity and the emergence of resistance mechanisms, such as the mcr-1 gene, which modifies the anionic target sites to reduce drug binding (Liu et al., 2016).

Other names
LPS-divalent cation bridgesOuter membrane cation-stabilized complexesMg2+/Ca2+ lipid cross-linksDivalent cation-phospholipid bridges
02

Mechanism of action

Competitive displacement of divalent cations (Mg2+, Ca2+) from phosphate groups of the outer membrane, leading to membrane disruption and self-promoted uptake.

03

Biological functions

Other
04

Disease associations

Infection
05

Safety considerations

NephrotoxicityNeurotoxicityDevelopment of antimicrobial resistance (e.g., mcr genes)
06

Interacting drugs

Polymyxin B

4 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)Membrane permeability assays

Beyond the preview

Go deeper on Gram-negative bacterial outer membrane phospholipids and divalent cation cross-bridges.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-negative bacterial outer membrane phospholipids and divalent cation cross-bridges.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call